{"parse":{"title":"Directive 65/65/EEC","pageid":7453685,"revid":654043556,"text":{"*":"<div class=\"mw-parser-output\"><p><b>Directive 65/65/EEC1</b> was the first European pharmaceutical directive. (Dated 26 January 1965.)\n</p>\n<div id=\"toc\" class=\"toc\"><input type=\"checkbox\" role=\"button\" id=\"toctogglecheckbox\" class=\"toctogglecheckbox\" style=\"display:none\" /><div class=\"toctitle\" lang=\"en\" dir=\"ltr\"><h2>Contents</h2><span class=\"toctogglespan\"><label class=\"toctogglelabel\" for=\"toctogglecheckbox\"></label></span></div>\n<ul>\n<li class=\"toclevel-1 tocsection-1\"><a href=\"#Intention\"><span class=\"tocnumber\">1</span> <span class=\"toctext\">Intention</span></a></li>\n<li class=\"toclevel-1 tocsection-2\"><a href=\"#Regulation\"><span class=\"tocnumber\">2</span> <span class=\"toctext\">Regulation</span></a></li>\n<li class=\"toclevel-1 tocsection-3\"><a href=\"#See_also\"><span class=\"tocnumber\">3</span> <span class=\"toctext\">See also</span></a></li>\n<li class=\"toclevel-1 tocsection-4\"><a href=\"#References\"><span class=\"tocnumber\">4</span> <span class=\"toctext\">References</span></a></li>\n<li class=\"toclevel-1 tocsection-5\"><a href=\"#External_links\"><span class=\"tocnumber\">5</span> <span class=\"toctext\">External links</span></a></li>\n</ul>\n</div>\n\n<h2><span class=\"mw-headline\" id=\"Intention\">Intention</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Directive_65/65/EEC&amp;action=edit&amp;section=1\" title=\"Edit section: Intention\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<p>The directive was a reaction<sup class=\"noprint Inline-Template Template-Fact\" style=\"white-space:nowrap;\">&#91;<i><a href=\"/wiki/Wikipedia:Citation_needed\" title=\"Wikipedia:Citation needed\"><span title=\"This claim needs references to reliable sources. (December 2012)\">citation needed</span></a></i>&#93;</sup> to the <a href=\"/wiki/Thalidomide\" title=\"Thalidomide\">Thalidomide</a> tragedy in the early 1960s, when thousands of babies were born with deformities as a result of their mothers taking the drug during pregnancy. The directive aimed at<sup class=\"noprint Inline-Template Template-Fact\" style=\"white-space:nowrap;\">&#91;<i><a href=\"/wiki/Wikipedia:Citation_needed\" title=\"Wikipedia:Citation needed\"><span title=\"This claim needs references to reliable sources. (December 2012)\">citation needed</span></a></i>&#93;</sup> harmonising standards for the approval of medicines within the then <a href=\"/wiki/European_Economic_Community\" title=\"European Economic Community\">European Economic Community</a>\n</p>\n<h2><span class=\"mw-headline\" id=\"Regulation\">Regulation</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Directive_65/65/EEC&amp;action=edit&amp;section=2\" title=\"Edit section: Regulation\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<p>The main article 3 of the directive requires that a <i>Proprietary medicinal product</i> could not be marketed within the community without prior authorisation of the competent authority of at least one member state. \n<i>Proprietary medicinal product</i> being defined as \"Any <i>ready-prepared</i> medicinal product placed on the market under a <i>special name</i> and in a <i>special pack</i>.\"\n</p>\n<h2><span class=\"mw-headline\" id=\"See_also\">See also</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Directive_65/65/EEC&amp;action=edit&amp;section=3\" title=\"Edit section: See also\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<ul><li><a href=\"/wiki/EudraLex\" title=\"EudraLex\">EudraLex</a></li>\n<li><a href=\"/wiki/Kefauver_Harris_Amendment\" title=\"Kefauver Harris Amendment\">Kefauver Harris Amendment</a></li>\n<li><a href=\"/wiki/Regulation_of_therapeutic_goods\" title=\"Regulation of therapeutic goods\">Regulation of therapeutic goods</a></li>\n<li><a href=\"/wiki/European_Medicines_Agency\" title=\"European Medicines Agency\">European Medicines Agency</a></li></ul>\n<h2><span class=\"mw-headline\" id=\"References\">References</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Directive_65/65/EEC&amp;action=edit&amp;section=4\" title=\"Edit section: References\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<ul><li>Maio G., <i>On the history of the Contergan (thalidomide) catastrophe in the light of drug legislation</i>, Dtsch Med Wochenschr. 2001 October 19;126(42):1183-6.</li>\n<li>Shah RR., Thalidomide, drug safety and early drug regulation in the UK, Adverse Drug React Toxicol Rev. 2001 Dec;20(4):199-255.</li></ul>\n<h2><span class=\"mw-headline\" id=\"External_links\">External links</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Directive_65/65/EEC&amp;action=edit&amp;section=5\" title=\"Edit section: External links\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<ul><li><a rel=\"nofollow\" class=\"external text\" href=\"http://eur-lex.europa.eu/LexUriServ/LexUriServ.do?uri=CELEX:31965L0065:EN:HTML\">Directive 65/65/EEC1</a></li>\n<li><a rel=\"nofollow\" class=\"external text\" href=\"http://www.euractiv.com/en/health/new-medicines-legislation/article-117531\">New medicines legislation</a> (overview)</li></ul>\n\n<!-- \nNewPP limit report\nParsed by mw2237\nCached time: 20180916020002\nCache expiry: 1900800\nDynamic content: false\nCPU time usage: 0.072 seconds\nReal time usage: 0.094 seconds\nPreprocessor visited node count: 272/1000000\nPreprocessor generated node count: 0/1500000\nPost\u2010expand include size: 3780/2097152 bytes\nTemplate argument size: 988/2097152 bytes\nHighest expansion depth: 11/40\nExpensive parser function count: 1/500\nUnstrip recursion depth: 0/20\nUnstrip post\u2010expand size: 0/5000000 bytes\nNumber of Wikibase entities loaded: 0/400\nLua time usage: 0.035/10.000 seconds\nLua memory usage: 1.11 MB/50 MB\n-->\n<!--\nTransclusion expansion time report (%,ms,calls,template)\n100.00%   80.018      1 -total\n 99.85%   79.895      2 Template:Citation_needed\n 70.85%   56.689      2 Template:Fix\n 43.31%   34.658      4 Template:Category_handler\n 22.27%   17.816      2 Template:Delink\n  4.98%    3.989      2 Template:Fix/category\n-->\n\n<!-- Saved in parser cache with key enwiki:pcache:idhash:7453685-0!canonical and timestamp 20180916020002 and revision id 654043556\n -->\n</div>"},"langlinks":[],"categories":[{"sortkey":"Directive 65 65 EEC","hidden":"","*":"All_articles_with_unsourced_statements"},{"sortkey":"Directive 65 65 EEC","hidden":"","*":"Articles_with_unsourced_statements_from_December_2012"},{"sortkey":"Directive 65 65 EEC","*":"Health_and_the_European_Union"},{"sortkey":"Directive 65 65 EEC","*":"Pharmaceuticals_policy"},{"sortkey":"65 65","*":"European_Union_directives_by_number"},{"sortkey":"Directive 65 65 EEC","*":"1965_in_law"},{"sortkey":"Directive 65 65 EEC","*":"1965_in_the_European_Economic_Community"}],"links":[{"ns":14,"exists":"","*":"Category:Articles with unsourced statements from December 2012"},{"ns":0,"exists":"","*":"EudraLex"},{"ns":0,"exists":"","*":"European Economic Community"},{"ns":0,"exists":"","*":"European Medicines Agency"},{"ns":0,"exists":"","*":"Kefauver Harris Amendment"},{"ns":0,"exists":"","*":"Regulation of therapeutic goods"},{"ns":0,"exists":"","*":"Thalidomide"},{"ns":4,"exists":"","*":"Wikipedia:Citation needed"}],"templates":[{"ns":10,"exists":"","*":"Template:Citation needed"},{"ns":10,"exists":"","*":"Template:Fix"},{"ns":10,"exists":"","*":"Template:Category handler"},{"ns":10,"exists":"","*":"Template:Fix/category"},{"ns":10,"exists":"","*":"Template:Delink"},{"ns":828,"exists":"","*":"Module:Unsubst"},{"ns":828,"exists":"","*":"Module:Category handler"},{"ns":828,"exists":"","*":"Module:Yesno"},{"ns":828,"exists":"","*":"Module:Category handler/data"},{"ns":828,"exists":"","*":"Module:Category handler/config"},{"ns":828,"exists":"","*":"Module:Category handler/shared"},{"ns":828,"exists":"","*":"Module:Category handler/blacklist"},{"ns":828,"exists":"","*":"Module:Namespace detect/data"},{"ns":828,"exists":"","*":"Module:Namespace detect/config"},{"ns":828,"exists":"","*":"Module:Arguments"},{"ns":828,"exists":"","*":"Module:Delink"},{"ns":828,"exists":"","*":"Module:No globals"}],"images":[],"externallinks":["http://eur-lex.europa.eu/LexUriServ/LexUriServ.do?uri=CELEX:31965L0065:EN:HTML","http://www.euractiv.com/en/health/new-medicines-legislation/article-117531"],"sections":[{"toclevel":1,"level":"2","line":"Intention","number":"1","index":"1","fromtitle":"Directive_65/65/EEC","byteoffset":102,"anchor":"Intention"},{"toclevel":1,"level":"2","line":"Regulation","number":"2","index":"2","fromtitle":"Directive_65/65/EEC","byteoffset":511,"anchor":"Regulation"},{"toclevel":1,"level":"2","line":"See also","number":"3","index":"3","fromtitle":"Directive_65/65/EEC","byteoffset":909,"anchor":"See_also"},{"toclevel":1,"level":"2","line":"References","number":"4","index":"4","fromtitle":"Directive_65/65/EEC","byteoffset":1041,"anchor":"References"},{"toclevel":1,"level":"2","line":"External links","number":"5","index":"5","fromtitle":"Directive_65/65/EEC","byteoffset":1349,"anchor":"External_links"}],"parsewarnings":[],"displaytitle":"Directive 65/65/EEC","iwlinks":[],"properties":[{"name":"defaultsort","*":"Directive 65 65 EEC"},{"name":"wikibase_item","*":"Q5280468"}]}}